Early interventions, improved screening access and tailored support services can help patients navigate cancer care
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Retrospective study aims to better stratify risk of disease recurrence
Timely referral to hospice care reduces emergency room admissions
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
62% of patients were progression-free at 18 months post-transplantation
Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant
Immunotherapy is preferred initial treatment for majority of patients
Recommendations focus on selecting the right biomarkers for the right setting
Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival
First prospective study looks at endocrine therapy interruption in premenopausal patients
Advertisement
Advertisement